#None #Drug Discovery #Xtalks #3D Models

Accelerate Predictive Drug Discovery with Scalable 3D Human Functional Models

In an era where the pharmaceutical industry is rapidly evolving, the shift from traditional animal testing to human-relevant models presents both opportunities and challenges. Xtalks is hosting a crucial webinar aimed at addressing these issues, revealing insights on how laboratories can effectively scale 3D human-functional models to improve drug discovery outcomes.

Understanding the Shift in Drug Discovery

The recent FDA Modernization Act 2.0 is a significant milestone for the industry, setting the stage for the adoption of Non-Animal Models (NAMs). However, despite this legislative push, many laboratories still struggle with the transition from traditional methods to scalable human-relevant alternatives, largely due to significant bottlenecks in scalability. This webinar seeks to explore how high-throughput systems, automated data collection, and advanced 3D biological models can bridge these gaps.

Key Topics of Discussion

During the session, the speaker will delve into the synergy between assay-ready cells and automated systems, highlighting why this combination is essential for achieving regulatory-grade NAMs. Attendees will learn about the innovative use of optogenetic and electrical stimulation techniques that allow for the creation of functionally mature 3D models. These advancements are particularly relevant for testing in neuromuscular diseases and assessing drug potency.

Real-World Applications and Future Prospects

The webinar promises to showcase practical applications in various fields, including neuromuscular and cardiac research. The focus will be on how the latest automated techniques for force and fluorescence measurements, combined with precision optogenetic controls, are paving the way for developing high-fidelity 3D models. These models stand to revolutionize the study of Duchenne muscular dystrophy and neurotoxin potency testing.

Moreover, attendees will be granted an exclusive preview of cutting-edge 96-well functional platforms designed to enhance contractile force and electrophysiological readings without compromising data accuracy. This represents a significant leap forward in data density and statistical validity for drug discovery research.

Registering for the Event

Participants interested in transforming their approach to drug discovery are encouraged to register for this insightful event. The live webinar is scheduled for Tuesday, May 26, 2026, at 12:00 PM EDT (9:00 AM PDT) and will feature Nicholas Geisse, PhD, CEO of Curi Bio, as the leading speaker.

Why Xtalks?

Xtalks stands at the forefront of the life sciences community, providing professionals in pharma, biotech, medtech, and healthcare with timely information and collaborative insights. The platform strives to empower industry leaders by equipping them with the knowledge needed to navigate this fast-evolving sector.

For more details or to sign up for the webinar, visit Accelerate Predictive Drug Discovery with Scalable 3D Human Functional Models.

Stay connected and informed by joining the Xtalks community and taking part in discussions that shape the future of drug discovery.